Inspection Record

Apollo Health and Beauty Care — Health Canada Inspection Findings

Health CanadaInspected 2022-01-25 7 findingsOther quality systemLabeling and packagingStability and storageLaboratory and QC controlsValidation and qualification

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

2Labeling and packaging

The quality agreement outlining the responsibilities for fabricating, packaging or labelling, and/or testing was inadequate.

3Stability and storage

The ongoing stability program for a drug was inadequate.

4Other quality system

The master formulas to control the manufacturing process were inadequate.

5Laboratory and QC controls

The specifications were not in writing and/or approved by the person in charge of the quality control department or the designated alternative. The written specifications were inadequate.

6Validation and qualification

Validation studies were not conducted in keeping with the predefined protocols.

7Other quality system

The assessment to release finished products was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-01-25. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Apollo Health and Beauty Care company profile — full history Health Canada documents, 2022 Go to Findings search